Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BrainMaster Technologies is a privately held U.S. neurotechnology and medical device company focused on clinical EEG, quantitative EEG (qEEG), brain mapping, and neurofeedback systems. The company develops and sells hardware, software, training, and support tools used by clinicians, researchers, and practitioners for brain assessment and neuromodulation-related applications. Its product portfolio includes commercial EEG and neurofeedback systems such as the Discovery, Atlantis, and Freedom series, along with qEEG-Pro reporting and BrainAvatar software. BrainMaster positions itself as a single-source provider for EEG acquisition, analysis, and neurofeedback workflows, with products used in clinical, research, educational, and remote-training settings. The company appears to operate primarily as a commercial medical device and neurofeedback technology vendor rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BrainMaster Technologies.